FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:693-698 September 3, 1998 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Remarkable advances have been made recently in our understanding of the molecular and genetic bases of disease. The potential therapeutic opportunities offered by these scientific findings, combined with the expanding needs of an aging population, have led to broad-based congressional support for increases in the National Institutes of Health budget. These developments have put into sharp relief the question of how to allocate growing budgetary resources among the various categories of medical research. In addition to the need to support basic-science research, investigators and policy analysts alike have recently emphasized the need to invest in translational research and clinical evaluative . . . [Full Text of this Article]

Why Uncertainty Endures

The Post-Innovation Innovation Process

Policy Implications

References

This article has been cited by other articles:

• Winkelman, C., Higgins, P. A., Chen, Y. J. K., Levine, A. D. (2007). Cytokines in Chronically Critically Ill Patients After Activity and Rest. Biol Res Nurs 8: 261-271 [Abstract]  
• Gelijns, A. C., Brown, L. D., Magnell, C., Ronchi, E., Moskowitz, A. J. (2005). Evidence, Politics, And Technological Change. Health Aff (Millwood) 24: 29-40 [Abstract] [Full Text]  
• Roberts, T. G. Jr., Chabner, B. A. (2004). Beyond Fast Track for Drug Approvals. NEJM 351: 501-505 [Full Text]  
• Morreim, E. H. (2003). A Dose of Our Own Medicine: Alternative Medicine, Conventional Medicine, and the Standards of Science. J Law Med Ethics 31: 222-235  
• Hall, J. E. (2003). The Promise of Translational Physiology. J. Neurophysiol. 89: 646-647 [Full Text]  
• Hall, J. E. (2002). The promise of translational physiology. Am. J. Physiol. Endocrinol. Metab. 283: E193-E194 [Full Text]  
• Hall, J. E. (2002). The promise of translational physiology. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L235-L236 [Full Text]  
• Hall, J. E. (2002). The promise of translational physiology. Am. J. Physiol. Renal Physiol. 283: F207-F208 [Full Text]  
• Hall, J. E. (2002). The promise of translational physiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: R1259-R1260 [Full Text]  
• Hall, J. E. (2002). The promise of translational physiology. Am. J. Physiol. Heart Circ. Physiol. 282: H803-H804 [Full Text]  
• Hall, J. E. (2002). The promise of translational physiology. J. Appl. Physiol. 92: 425-426 [Full Text]  
• Gelijns, A. C., Thier, S. O. (2002). Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections. JAMA 287: 72-77 [Abstract] [Full Text]  
• Hall, J. E. (2001). The promise of translational physiology. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1127-G1128 [Full Text]  
• POBER, J. S., NEUHAUSER, C. S., POBER, J. M. (2001). Obstacles facing translational research in academic medical centers. FASEB J. 15: 2303-2313 [Abstract] [Full Text]  
• Hall, J. E. (2001). The promise of translational physiology. Am. J. Physiol. Cell Physiol. 281: C1411-C1412 [Full Text]  
• Gelijns, A. C., Zivin, J. G., Nelson, R. R. (2001). Uncertainty and Technological Change in Medicine. Journal of Health Politics, Policy and Law 26: 913-924  
• Block, A. J. (1999). Translational Research Is Hurting. Chest 115: 311-311 [Full Text]  
• Singer, B. H., Manton, K. G. (1998). The effects of health changes on projections of health service needs for the elderly population of the United States. Proc. Natl. Acad. Sci. USA 95: 15618-15622 [Abstract] [Full Text]